LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V. (NASDAQ:OFIX) (the Company) announced today
that it has reached an agreement with Brainlab for an integration of
their Phoenix™ MIS and Firebird™ Pedicle Screw Systems into the latest
generation of Brainlab spinal navigation systems.
"Our collaboration with Brainlab is another step in promoting new
technologies for procedures such as minimally invasive and spinal
deformity surgery. We are excited to partner with Brainlab to educate
and promote the intra-operative advantages of its different image guided
surgery platforms when used in conjunction with our Phoenix MIS and
Firebird spinal fixation systems," said Robert Vaters, President and
Chief Executive Officer of Orthofix. The agreement allows for the
integration and co-marketing of the technologies, which permits
preoperative planning and real-time positioning of spinal fixation
devices in technically challenging spinal fusions procedures.
"We believe that the combination of our navigation technology with
minimally invasive surgical instrumentation can change the way spinal
procedures are done today. It will not only increase the accuracy of the
implant placement but also provide a better orientation during surgery
and has the potential to reduce the intra-operative radiation exposure.
We are very excited to add the Orthofix products to our supported
portfolio for minimally invasive spinal navigation," said Martin Immerz,
Global Product Line Director Orthopedics of Brainlab.
The parties are introducing the partnership during the 2012 SpineWeek
Meeting being held May 28 — June 1 in Amsterdam, The Netherlands.
About Orthofix:
Orthofix International N.V. is a diversified, global medical device
company focused on developing and delivering innovative repair and
regenerative solutions to the spine and orthopedic markets. Orthofix's
products are widely distributed around the world to orthopedic surgeons
and patients via Orthofix's sales representatives and its subsidiaries,
and via collaborations with other leading orthopedic product companies.
In addition, Orthofix is collaborating on R&D activities with leading
research and clinical organizations such as the Musculoskeletal
Transplant Foundation, the Orthopedic Research and Education Foundation,
and Texas Scottish Rite Hospital for Children. For more information
about Orthofix, please visit www.orthofix.com.
About Brainlab:
Brainlab develops, manufactures and markets software-driven medical
technology that supports targeted, less-invasive treatment. Core
products are image-guided systems and software that provide real-time
information used for surgical navigation and radiosurgical planning and
delivery.
Brainlab technology drives collaboration between hospitals and
clinicians from a wide variety of subspecialties—from neurosurgery and
oncology to orthopedics, ENT, CMF and spine & trauma. This integration
delivers better access to improved and more efficient treatment.
Founded in 1989, the privately held Brainlab group has more than 5,000
systems installed in over 80 countries. Based in Munich, Germany,
Brainlab employs 1,020 people in 17 offices worldwide. To learn more,
visit www.brainlab.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Director
of Investor Relations and Business Development
markquick@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media